Standard
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. / Madsen, K B; Askov-Hansen, C; Naimi, R M; Brandt, C F; Hartmann, B; Holst, Jens Juul; Mortensen, P B; Jeppesen, P B.
In:
Regulatory Peptides, Vol. 184, No. 10, 10.06.2013, p. 30-9.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Madsen, KB, Askov-Hansen, C, Naimi, RM, Brandt, CF
, Hartmann, B, Holst, JJ, Mortensen, PB
& Jeppesen, PB 2013, '
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study',
Regulatory Peptides, vol. 184, no. 10, pp. 30-9.
https://doi.org/10.1016/j.regpep.2013.03.025
APA
Madsen, K. B., Askov-Hansen, C., Naimi, R. M., Brandt, C. F.
, Hartmann, B., Holst, J. J., Mortensen, P. B.
, & Jeppesen, P. B. (2013).
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
Regulatory Peptides,
184(10), 30-9.
https://doi.org/10.1016/j.regpep.2013.03.025
Vancouver
Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF
, Hartmann B, Holst JJ et al.
Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study.
Regulatory Peptides. 2013 Jun 10;184(10):30-9.
https://doi.org/10.1016/j.regpep.2013.03.025
Author
Madsen, K B ; Askov-Hansen, C ; Naimi, R M ; Brandt, C F ; Hartmann, B ; Holst, Jens Juul ; Mortensen, P B ; Jeppesen, P B. / Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. In: Regulatory Peptides. 2013 ; Vol. 184, No. 10. pp. 30-9.
Bibtex
@article{db12f6962ab84b8fb42c91a65e764a3e,
title = "Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study",
abstract = "The ileocolonic brake is impaired in short bowel syndrome (SBS) patients with distal bowel resections. An attenuated meal-stimulated hormone secretion may cause gastric hypersecretion, rapid gastric and intestinal transit and a poor adaptation. Attempting to restore this ileocolonic brake, this study evaluated the acute effects of continuous intravenous administration of glucagon-like peptide (GLP) 1 and 2, alone or in combination, on gastrointestinal function in SBS patients.",
author = "Madsen, {K B} and C Askov-Hansen and Naimi, {R M} and Brandt, {C F} and B Hartmann and Holst, {Jens Juul} and Mortensen, {P B} and Jeppesen, {P B}",
note = "Copyright {\textcopyright} 2013 Elsevier B.V. All rights reserved.",
year = "2013",
month = jun,
day = "10",
doi = "10.1016/j.regpep.2013.03.025",
language = "English",
volume = "184",
pages = "30--9",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "10",
}
RIS
TY - JOUR
T1 - Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study
AU - Madsen, K B
AU - Askov-Hansen, C
AU - Naimi, R M
AU - Brandt, C F
AU - Hartmann, B
AU - Holst, Jens Juul
AU - Mortensen, P B
AU - Jeppesen, P B
N1 - Copyright © 2013 Elsevier B.V. All rights reserved.
PY - 2013/6/10
Y1 - 2013/6/10
N2 - The ileocolonic brake is impaired in short bowel syndrome (SBS) patients with distal bowel resections. An attenuated meal-stimulated hormone secretion may cause gastric hypersecretion, rapid gastric and intestinal transit and a poor adaptation. Attempting to restore this ileocolonic brake, this study evaluated the acute effects of continuous intravenous administration of glucagon-like peptide (GLP) 1 and 2, alone or in combination, on gastrointestinal function in SBS patients.
AB - The ileocolonic brake is impaired in short bowel syndrome (SBS) patients with distal bowel resections. An attenuated meal-stimulated hormone secretion may cause gastric hypersecretion, rapid gastric and intestinal transit and a poor adaptation. Attempting to restore this ileocolonic brake, this study evaluated the acute effects of continuous intravenous administration of glucagon-like peptide (GLP) 1 and 2, alone or in combination, on gastrointestinal function in SBS patients.
U2 - 10.1016/j.regpep.2013.03.025
DO - 10.1016/j.regpep.2013.03.025
M3 - Journal article
C2 - 23511332
VL - 184
SP - 30
EP - 39
JO - Regulatory Peptides
JF - Regulatory Peptides
SN - 0167-0115
IS - 10
ER -